Effectiveness of Antiseizure Medication Triple Therapy in Patients With Glioma With Refractory Epilepsy: An Observational Cohort Study

BACKGROUND AND OBJECTIVES: Approximately 10% of patients with glioma with epilepsy need antiseizure medication (ASM) triple therapy due to refractory epilepsy. The aim of this study was to evaluate whether levetiracetam combined with valproic acid and clobazam (LEV + VPA + CLB), a frequently prescri...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Meer, Pim B., Dirven, Linda, Fiocco, Marta, Vos, Maaike J., Kouwenhoven, Mathilde C.M., van den Bent, Martin J., Taphoorn, Martin J.B., Koekkoek, Johan A.F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10104607/
https://www.ncbi.nlm.nih.gov/pubmed/36754633
http://dx.doi.org/10.1212/WNL.0000000000206852

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10104607/
https://www.ncbi.nlm.nih.gov/pubmed/36754633
http://dx.doi.org/10.1212/WNL.0000000000206852

Ejemplares similares